ArticleJournal of experimental & clinical cancer research : CR2016

Low dose of lenalidmide and PI3K/mTOR inhibitor trigger synergistic cytoxicity in activated B cell-like subtype of diffuse large B cell lymphoma.

Zhen Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.